investors & media
NASDAQ: (common stock)
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Resilience to acquire bluebird’s clinical and commercial suspension lentiviral vector manufacturing facility in North Carolina , retaining all current employees at the site Alliance designed to foster best in class cell therapy product and manufacturing innovation through risk-sharing andRead more
SKYSONA is the first and only gene therapy approved in the EU to treat early CALD CALD is a rare neurodegenerative disease that can lead to progressive, irreversible loss of neurologic function, and death One-time treatment with SKYSONA has been shown to have a durable effect in improving survivalRead more
EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) confirms favorable benefit-risk balance of ZYNTEGLO Company has informed EMA of lift of voluntary temporary marketing suspension CAMBRIDGE, Mass. --(BUSINESS WIRE)--Jul. 9, 2021-- bluebird bio, Inc .Read more